Patients scheduled for colonoscopy
Conditions
Interventions
None listed
Sponsors
Keio university hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients attempted MC for screening and pretreated by two-time method with SULPREP
Exclusion criteria
Exclusion criteria: SULPREP administration is contraindicated in patients with a history of hypersensitivity to any of the components of this drug, gastrointestinal obstruction or suspected intestinal obstruction, intestinal perforation, gastric evacuation failure, toxic megacolon, severe renal dysfunction (creatinine clearance less than 30 mL/min), patients who cannot come to the hospital on the morning of the colonoscopy, and patients who cannot correctly understand the dosage and administration of SULPREP
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Percentage of patients who were able to perform MC by pretreatment of two-time method with SULPREP | — |
Secondary
| Measure | Time frame |
|---|---|
| (1) Patient's age, gender, and regular use of constipation medication (2) Time from the arrival to the hospital until MC could be started (3) Amount of SULPREP and water taken (4) Degree of washing during colonoscopy (5) Adverse events (6) Inspection time (7) Rate of reaching the appendix (8) Adenoma detection rate (9) Serrated lesion detection rate | — |
Countries
Japan
Contacts
Public ContactAtsushi Nakayama
Keio University Hospital Cancer Center
Outcome results
None listed